More specifically, mutations in NRG1/ERBB4 lead to impairments in AMPA and NMDA receptors’ spines structure and plasticity [70], and it has been attributed to cognitive deficits observed in SCZ patients [71]. This evidence concerns the gene NRG1 and Cognitive impairment.